Report

Global Ablation Device Market Size study,by Application (Cardiovascular, Cancer, Pain Management, Orthopedics) by product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Global Ablation Device Market to reach USD 8.9billion by 2027.
Global Ablation Device Market is valued at approximately USD 4.3 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.9 % over the forecast period 2021-2027. Ablation devices offer a minimally invasive alternative to traditional surgical treatment of liver, prostrate, kidney and lung cancer. Emergence of next generation ablation products and technologies is expected to fuel the Ablation Device Market. increase in prevalence of chronic diseases among elders is also propelling the market growth. For instance, according to United Nations World Population Ageing 2019 report, the number of people aged 65 years or above will reach nearly 1 billion by 2027, increasing generic population and prevalence of chronic diseases among elders, fueling the market growth.

However, reuse and reprocessing of devices in developing countries may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Ablation Device Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is expected to lead the market by holding largest share in the global market. The responsible factor is expected to be the rapidly growing elderly population, and high adoption rate of ablation devices in the region. However, the Asia-Pacific is estimated to follow North America, being second largest market for the ablation devices. The factors fueling the growth are focus over the key players, large population and rising prevalence of cancer.


Major market player included in this report are:
Johnson & Johnson
Medtronic Inc,
Biosense Webster Inc,
St. Jude Medical Inc,
Boston Scientific Corporation
CONMED Corporation
AngioDynamics Inc.
AtriCure Inc.
Smith & Nephew plc
Olympus Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Radiofrequency
Ultrasound (ESWL, HIFU)
Laser, Electrical (Argon Plasma, IRE)
Cryotherapy
Microwave
Hydrothermal

By Application:
Cardiovascular
Cancer
Pain Management
Orthopedics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018-19
Base year - 2019-2020
Forecast period - 2021 to 2027.

Target Audience of the Global Ablation Device MARKET Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors